11/06/2025

Eli Lilly, Novo Nordisk Negotiating Deal with Administration on Obesity Drug Prices

Novo Nordisk makes the popular weight loss drug Wegovy

The Trump administration is negotiating an agreement with pharmaceutical companies Novo Nordisk and Eli Lilly to offer some of their weight loss drugs at a lower price through "TrumpRx," sources familiar with the talks told ABC News.

Under the pending agreements, a month's supply of the drugs would cost roughly $149 and be covered for some Medicare beneficiaries, one source told ABC News.

Discussions between the pharmaceutical companies and the administration are still ongoing, the sources said. If an agreement is reached, an announcement is expected as soon as this week, according to the sources.

Please select this link to read the complete article from ABC News.